
Lucerno Dynamics, based in Morrisville, US, develops and markets systems for radiolabeled biomarker detection.
Lucerno Dynamics, based in Morrisville, US, develops and markets systems for detecting and quantifying radiolabeled biomarkers. Their core mission is to enhance the accuracy and safety of nuclear medicine procedures, ensuring optimal care with minimal risk to patients. The company’s flagship product, the Lara® System, addresses the critical need for confirming injection accuracy in nuclear medicine, thereby improving patient outcomes and operational efficiency for healthcare providers.
Notable affiliated people include experts in nuclear medicine and medical device innovation. Lucerno Dynamics has garnered attention from key investors in the healthcare technology sector. Among their achievements, the successful development and deployment of the Lara® System stand out, significantly impacting the field of nuclear medicine by providing a reliable method to verify injection accuracy. This innovation has improved procedural safety and efficacy, reinforcing Lucerno Dynamics' commitment to advancing medical technology.

Lucid Diagnostics
luciddx.com

A LaRue Company
alaruecompany.com

Xact Medical
xactmedical.com

LumaCyte
lumacyte.com

LumiThera
lumithera.com

Lucence
lucence.com

OnLume
onlume.com

LKC Technologies

Perceptive Navigation

Lumedica

WaveFront Dynamics

Invenio Imaging

LightningCath
lightningcath.com

Bright Uro
brighturo.com

Real Time Imaging Technologies
Companies similar to Lucerno Dynamics include Lucid Diagnostics, A LaRue Company, Xact Medical and LumaCyte.
Lucerno Dynamics was founded in 2011.
Lucerno Dynamics' headquarters is located in Cary, NC, US.
Lucerno Dynamics' most recent funding round was for $472.7k (USD) in September 2023.
As of Sep 1, 2023, Lucerno Dynamics has raised a total of $9.2M (USD).
Lucerno Dynamics has 13 employees as of Feb 5, 2024.